Advances in RSV Immunoprophylaxis: Evolution, Efficacy, and Implementation Challenges
{{output}}
Respiratory syncytial virus (RSV) poses a critical global health challenge, causing more than 33.1 million acute lower respiratory tract infections and more than 118 000 deaths annually in children younger than 5 years of age. The burden falls disproportionate... ...
